To test the mechanism in vivo, we treated female and male SLC3A1 KO mice with a NAD+ precursor, NMN, for two weeks (Fig. 8G), to determine if it could rescue the sex differences of cystinuria. Here, SLC3A1 is linked to cystinuria.